Cargando…

Allergists Can Safely Evaluate and Revaccinate Individuals With Immediate Allergic Reactions to mRNA COVID-19 Vaccines

Detalles Bibliográficos
Autores principales:	Greenhawt, Matthew, Abrams, Elissa M, Shaker, Marcus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753029/ https://www.ncbi.nlm.nih.gov/pubmed/35028331 http://dx.doi.org/10.1093/ofid/ofab584

Ejemplares similares

COVID-19 and the importance of effective risk communication with children
por: Abrams, Elissa M, et al.
Publicado: (2022)

Patients with suspected allergic reactions to COVID‐19 vaccines can be safely revaccinated after diagnostic work‐up
por: Rasmussen, Trine Holm, et al.
Publicado: (2021)

To prevent the allergic disease: the dream of the allergist
por: Ciprandi, Giorgio, et al.
Publicado: (2020)

Elicitors of severe allergic reactions – reports from allergists and emergency doctors
por: Hohenadel, M., et al.
Publicado: (2017)

Allergists and COVID-vaccine: which is the actual risk of reactions in allergic patients?
por: Pucciarini, Francesco, et al.
Publicado: (2022)

What the COVID-19 Pandemic Can Teach Us About Resource Stewardship and Quality in Health Care
por: Abrams, Elissa M., et al.
Publicado: (2021)

Frequency of Revaccination against Smallpox
por: Baron, Samuel, et al.
Publicado: (2003)

Clinician Wellness During the COVID-19 Pandemic: Extraordinary Times and Unusual Challenges for the Allergist/Immunologist
por: Bansal, Priya, et al.
Publicado: (2020)

A Cost-Effectiveness Evaluation of Hospitalizations, Fatalities, and Economic Outcomes Associated with Universal Versus Anaphylaxis Risk-Stratified COVID-19 Vaccination Strategies
por: Shaker, Marcus, et al.
Publicado: (2021)

School Attendance, Asthma Risk, and COVID-19 in Children
por: Abrams, Elissa M., et al.
Publicado: (2021)

COVID-19 vaccines: addressing hesitancy in young people with allergies
por: Abrams, Elissa M, et al.
Publicado: (2021)

The COVID-19 Pandemic in 2021: Avoiding Overdiagnosis of Anaphylaxis Risk While Safely Vaccinating the World
por: Greenhawt, Matthew, et al.
Publicado: (2021)

PEG/Polysorbate Skin Testing Has No Utility in the Assessment of Suspected Allergic Reactions to SARS-CoV-2 Vaccines
por: Greenhawt, Matthew, et al.
Publicado: (2021)

Climate Change, Migration, and Allergic Respiratory Diseases: An Update for the Allergist
por: D'Amato, Gennaro, et al.
Publicado: (2011)

Dermatology for the Allergist
por: Kim, Dennis, et al.
Publicado: (2010)

Revaccination with Bacille Calmette-Guérin: Some issues to consider
por: Datta, Manjula, et al.
Publicado: (2023)

On Revaccination
por: Braidwood, P. M.
Publicado: (1871)

Revaccination
Publicado: (1884)

On Revaccination
por: Russell, James B.
Publicado: (1871)

Revaccination
Publicado: (1858)

Revaccination
Publicado: (1872)

Revaccination
Publicado: (1871)

Primary care provider-reported prevalence of vaccine and polyethylene glycol allergy in Canada
por: Abrams, Elissa M., et al.
Publicado: (2021)

The Differences and Similarities between Allergists and Non-Allergists for Penicillin Allergy Management
por: Suetrong, Nayot, et al.
Publicado: (2014)

207 Approach of Paediatric Allergists to Allergen Immunotherapy in Severe Persistent Allergic Rhinitis
por: Fiocchi, Alessandro, et al.
Publicado: (2012)

Health and Economic Outcomes of Home Maintenance Allergen Immunotherapy in Select Patients with High Health Literacy during the COVID-19 Pandemic: A Cost-Effectiveness Analysis During Exceptional Times
por: Shaker, Marcus S., et al.
Publicado: (2020)

Universal Revaccination
Publicado: (1902)

The Age for Revaccination
Publicado: (1888)

Observations on Revaccination
por: Vleminckx,, et al.
Publicado: (1860)

Importance of Revaccination
Publicado: (1871)

Incidence of immediate allergic reactions to mRNA COVID-19 vaccines in adults with drug allergies and other allergic disorders
por: Marković, Ivan, et al.
Publicado: (2022)

The Challenges and Opportunities for Shared Decision Making Highlighted by COVID-19
por: Abrams, Elissa M., et al.
Publicado: (2020)

The COVID-19 pandemic: Adverse effects on the social determinants of health in children and families
por: Abrams, Elissa M., et al.
Publicado: (2022)

Reply to “How important is the second dose of the COVID-19 mRNA vaccine?”
por: Shaker, Marcus S., et al.
Publicado: (2021)

388 Drug Hypersensitivity Reactions in Hospitalized Patients: What is the Role of the Allergist?
por: Tanno, Luciana Kase, et al.
Publicado: (2012)

Estimation of Health and Economic Benefits of a Small Automatic External Defibrillator for Rapid Treatment of Sudden Cardiac Arrest (SMART): A Cost-Effectiveness Analysis
por: Shaker, Marcus S., et al.
Publicado: (2022)

Management of patients with immediate reactions to COVID-19 vaccines
por: Picard, Matthieu, et al.
Publicado: (2023)

COVID-19, health disparities, and what the allergist-immunologist can do
por: Ogbogu, Princess U., et al.
Publicado: (2021)

Should Younger Siblings of Peanut-Allergic Children Be Assessed by an Allergist before Being Fed Peanut?
por: Liem, Joel J, et al.
Publicado: (2008)

Revaccination and Medical Examinations
Publicado: (1902)

Cannot write session to /tmp/vufind_sessions/sess_7lgrjetohntlc21rhdfkpobrq5